Dr. Daniel Flora, MD
Claim this profileSt. Elizabeth Healthcare
Studies Breast Cancer
Studies Cancer
10 reported clinical trials
20 drugs studied
Area of expertise
1Breast Cancer
HER2 negative
ER positive
Stage IV
2Cancer
Stage IV
Stage III
Stage I
Affiliated Hospitals
Clinical Trials Daniel Flora, MD is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Hormone Therapy
for Breast Cancer
This phase II clinical trial studies how well fulvestrant and palbociclib works in treating older patients with breast cancer that responds to hormone treatment (hormone responsive) that cannot be removed by surgery. Estrogen can cause the growth of estrogen-receptor-positive breast cancer cells. Hormone therapy using fulvestrant may fight estrogen-receptor-positive breast cancer by blocking the use of estrogen by the tumor cells. Palbociclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving fulvestrant together with palbociclib may be an effective treatment for hormone responsive breast cancer.
Recruiting3 awards Phase 29 criteria
More about Daniel Flora, MD
Clinical Trial Related9 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Daniel Flora, MD has experience with
- Paclitaxel
- Carboplatin
- Nivolumab
- Abemaciclib
- Placebo
- BXQ-350
Breakdown of trials Daniel Flora, MD has run
Breast Cancer
Cancer
Melanoma
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel Flora, MD specialize in?
Daniel Flora, MD focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 negative patients, or patients who are ER positive.
Is Daniel Flora, MD currently recruiting for clinical trials?
Yes, Daniel Flora, MD is currently recruiting for 5 clinical trials in Edgewood Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Daniel Flora, MD has studied deeply?
Yes, Daniel Flora, MD has studied treatments such as Paclitaxel, Carboplatin, Nivolumab.
What is the best way to schedule an appointment with Daniel Flora, MD?
Apply for one of the trials that Daniel Flora, MD is conducting.
What is the office address of Daniel Flora, MD?
The office of Daniel Flora, MD is located at: St. Elizabeth Healthcare, Edgewood, Kentucky 41017 United States. This is the address for their practice at the St. Elizabeth Healthcare.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.